Nathan SD - Search Results

1

Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results.

Nathan SD, Argula R, Trivieri MG, Aziz S, Gay E, Medarov B, Parambil J, Raina A, Risbano MG, Thenappan T, Soto JS, Bell H, Lacasse V, Sista P, Di Marino M, Smart A, Hawkes B, Nelson E, Bull T, Tapson V, Waxman A. Nathan SD, et al. Eur Respir J. 2024 Jun 6;63(6):2400172. doi: 10.1183/13993003.00172-2024. Print 2024 Jun. Eur Respir J. 2024. PMID: 38811045 Free PMC article. Clinical Trial.

2

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis.

Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, Burton N, Barnett SD. Nathan SD, et al. Respir Med. 2010 Jul;104(7):1035-41. doi: 10.1016/j.rmed.2010.02.008. Epub 2010 Mar 2. Respir Med. 2010. PMID: 20199856 Free article.

3

Pulmonary hypertension secondary to interstitial lung disease.

Shlobin OA, Nathan SD. Shlobin OA, et al. Among authors: nathan sd. Expert Rev Respir Med. 2011 Apr;5(2):179-89. doi: 10.1586/ers.11.11. Expert Rev Respir Med. 2011. PMID: 21510729 Review.

4

Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation.

Shlobin OA, Nathan SD. Shlobin OA, et al. Among authors: nathan sd. Eur Respir J. 2012 Jun;39(6):1520-33. doi: 10.1183/09031936.00175511. Epub 2012 Jan 12. Eur Respir J. 2012. PMID: 22241743 Free article. Review.

5

Hypersensitivity pneumonitis and pulmonary hypertension: how the breeze affects the squeeze.

Nathan SD. Nathan SD. Eur Respir J. 2014 Aug;44(2):287-8. doi: 10.1183/09031936.00061214. Eur Respir J. 2014. PMID: 25082906 Free article. No abstract available.

6

Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease.

Shin S, King CS, Brown AW, Albano MC, Atkins M, Sheridan MJ, Ahmad S, Newton KM, Weir N, Shlobin OA, Nathan SD. Shin S, et al. Among authors: nathan sd. Respir Med. 2014 Nov;108(11):1626-32. doi: 10.1016/j.rmed.2014.08.009. Epub 2014 Sep 2. Respir Med. 2014. PMID: 25225149 Free article.

7

Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.

Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Wells AU, Shao L, Zhou H, Henig N, Szwarcberg J, Gillies H, Montgomery AB, O'Riordan TG. Raghu G, et al. Among authors: nathan sd. Eur Respir J. 2015 Nov;46(5):1370-7. doi: 10.1183/13993003.01537-2014. Epub 2015 Aug 6. Eur Respir J. 2015. PMID: 26250495 Free article. Clinical Trial.

8

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.

Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Lancaster L, Lederer DJ, Leff JA, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, King TE Jr. Noble PW, et al. Among authors: nathan sd. Eur Respir J. 2016 Jan;47(1):243-53. doi: 10.1183/13993003.00026-2015. Epub 2015 Dec 2. Eur Respir J. 2016. PMID: 26647432 Free PMC article.

9

Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis.

Shin S, King CS, Puri N, Shlobin OA, Brown AW, Ahmad S, Weir NA, Nathan SD. Shin S, et al. Among authors: nathan sd. Eur Respir J. 2016 May;47(5):1445-51. doi: 10.1183/13993003.01532-2015. Epub 2016 Feb 4. Eur Respir J. 2016. PMID: 26846836 Free article.

10

Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science.

Hassoun PM, Nathan SD. Hassoun PM, et al. Among authors: nathan sd. Eur Respir J. 2016 Jun;47(6):1615-7. doi: 10.1183/13993003.00395-2016. Eur Respir J. 2016. PMID: 27246075 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page